Array CEO: 'Partnerships Smart While Cancer Drug Develops' - Presented by: The Aol. On Network

Array BioPharma will soon be entering a pivotal trial for its wholly owned blood cancer drug and investors should know its outlook by the end of 2014, says the company's CEO Ron Squarer. Array is also partnering with AstraZeneca and Novartis on a number of other cancer drugs with trials soon getting underway that could transform the company by year end.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.13 0.26 ▼ 1.59%
FB $ 59.72 0.63 ▲ 1.07%
YHOO $ 36.35 2.14 ▲ 6.26%
INTC $ 26.93 0.16 ▲ 0.60%
SIRI $ 3.17 0.08 ▲ 2.59%
QQQ $ 86.18 1.13 ▲ 1.33%
AA $ 13.42 0.37 ▲ 2.84%
GE $ 26.12 0.30 ▲ 1.16%

As of 4/16/2014, 04:05 PM
More Most Active